Provided by Tiger Trade Technology Pte. Ltd.

Exact Sciences

103.45
+0.06000.06%
Post-market: 103.41-0.0400-0.04%19:45 EST
Volume:2.37M
Turnover:245.38M
Market Cap:19.74B
PE:-93.87
High:103.67
Open:103.60
Low:103.38
Close:103.39
52wk High:103.67
52wk Low:38.81
Shares:190.81M
Float Shares:187.46M
Volume Ratio:1.16
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1021
EPS(LYR):-1.1021
ROE:-8.66%
ROA:-1.59%
PB:8.22
PE(LYR):-93.87

Loading ...

Analysts Are Bullish on These Healthcare Stocks: Nano-X Imaging (NNOX), Exact Sciences (EXAS)

TIPRANKS
·
Nov 21, 2025

Exact Sciences downgraded to Neutral from Buy at BTIG

TIPRANKS
·
Nov 21, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Apollo Global, Exact Sciences, Eaton

Reuters
·
Nov 21, 2025

Leerink Partners Downgrades Exact Sciences to Market Perform From Outperform, Adjusts PT to $105 From $100

MT Newswires Live
·
Nov 21, 2025

Exact Sciences downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
Nov 21, 2025

Midday Fly By: Nvidia reports Q3 beat, Abbott buys Exact Sciences

TIPRANKS
·
Nov 21, 2025

BREAKINGVIEWS-Abbott’s colon-screening deal stinks financially

Reuters
·
Nov 21, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Oddity Tech, Central Bancompany, Shoe Carnival

Reuters
·
Nov 21, 2025

M&A News: Exact Sciences Stock (EXAS) Jumps 18% on Abbott’s $21B Acquisition

TIPRANKS
·
Nov 20, 2025

Baird Downgrades Exact Sciences to Neutral From Outperform, Adjusts PT to $105 From $88

MT Newswires Live
·
Nov 20, 2025

Exact Sciences downgraded to Neutral from Outperform at Baird

TIPRANKS
·
Nov 20, 2025

Exact Sciences rises 17.9%

TIPRANKS
·
Nov 20, 2025

Abbott Shares Down 1.2%

THOMSON REUTERS
·
Nov 20, 2025

Exact Sciences Shares Jump 17.9% After Abbott to Buy Co in $23 Bln Deal

THOMSON REUTERS
·
Nov 20, 2025

Exact Sciences Should Give Abbott's Diagnostics Business a Needed Boost -- Market Talk

Dow Jones
·
Nov 20, 2025

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

Dow Jones
·
Nov 20, 2025

BRIEF-Abbott -Deal Expected To Be Dilutive To Adjusted Earnings Per Share Through 2027- SEC Filing

Reuters
·
Nov 20, 2025

Exact Sciences Soars 18% as Abbott Bolsters Diagnostics Portfolio with up to $23 Billion Buyout of Exact Sciences

Reuters
·
Nov 20, 2025

Abbott: Exact Sciences to Pay or Cause to Be Paid by a U.S. Person to Abbott $628.7 Mln IF Deal Is Terminated Under Some Circumstances - SEC Filing

THOMSON REUTERS
·
Nov 20, 2025

Rpt-Top Alert-Abbott to Acquire Exact Sciences for Estimated Enterprise Value of $23 Bln

THOMSON REUTERS
·
Nov 20, 2025